| Name | HDAC-IN-4 |
|---|
| Description | HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC50s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activity[1]. |
|---|---|
| Related Catalog | |
| Target |
pIC50: 7.2 (HDAC6), and 6.8 (HDAC10)[1] |
| In Vitro | HDAC-IN-4 inhibits HDAC1, HDAC2, HDAC3, HDAC8 and HDAC10 with pIC50s of 5.5, 4.6, 5.4, 5.4, 6.7 in FRET assay, respectively[1]. HDAC-IN-4 is more potent against HDAC6 than Tubastatin A, suggests that HDAC-IN-4 may be a better HDAC6 probe than Tubastatin A[1]. |
| References |
| Molecular Formula | C20H21N3O2 |
|---|---|
| Molecular Weight | 335.40 |